Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 248 of 1,261

  1. US 11401328

    Antibodies binding to ILT4

    Five Prime Therapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  2. US 11401322

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  3. US 11401286

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  4. US 11400116

    Systems and methods for targeting cancer cells

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  5. US 11400105

    Anti-inflammatory properties of marine lipid compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  6. US 11400143

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  7. US 11400096

    Small molecules for the treatment of autoimmune disorders

    The Board of Regents of the University of Texas System · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  8. US 11401332

    Proteolytically cleavable chimeric polypeptides and methods of use thereof

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  9. US 11401246

    Triazole glycolate oxidase inhibitors

    Century Therapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  10. US 11400150

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  11. US 11401503

    Methods of growing tumor infiltrating lymphocytes in gas-permeable containers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  12. US 11400123

    Combination product for prophylaxis and treatment of irritable bowel syndrome

    PrecisionBiotics Group Limited · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  13. US 11400118

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  14. US 11401517

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  15. US 11401387

    Photocontrolled dynamic covalent linkers for polymer networks

    Northwestern University · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  16. US 11401341

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  17. US 11401346

    Nucleic acids encoding plasma kallikrein binding proteins

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  18. US 11401532

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  19. US 11401461

    Zirconia sintered body containing fluorescent agent

    KURARAY NORITAKE DENTAL INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  20. US 11401317

    Human-CD123-targeting chimeric receptor ligand and application thereof

    Nanjing Legend Biotech Co., Ltd · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  21. US 11401314

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  22. US 11401306

    HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

    PDS Biotechnology Corporation · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  23. US 11401267

    Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof

    NURIX THERAPEUTICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  24. US 11401320

    QTY FC fusion receptor proteins

    Avalon GloboCare Corp. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.